Biodegradable Peptide-Silica Nanodonuts

We report hybrid organosilica toroidal particles containing a short peptide sequence as the organic component of the hybrid systems. Once internalised in cancer cells, the presence of the peptide allows for interaction with peptidase enzymes, which attack the nanocarrier effectively triggering its s...

Full description

Saved in:
Bibliographic Details
Published in:Chemistry : a European journal Vol. 22; no. 11; pp. 3697 - 3703
Main Authors: Maggini, Laura, Travaglini, Leana, Cabrera, Ingrid, Castro-Hartmann, Pablo, De Cola, Luisa
Format: Journal Article
Language:English
Published: Germany Blackwell Publishing Ltd 07-03-2016
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report hybrid organosilica toroidal particles containing a short peptide sequence as the organic component of the hybrid systems. Once internalised in cancer cells, the presence of the peptide allows for interaction with peptidase enzymes, which attack the nanocarrier effectively triggering its structural breakdown. Moreover, these biodegradable nanovectors are characterised by high cellular uptake and exocytosis, showing great potential as biodegradable drug carriers. To demonstrate this feature, doxorubicin was employed and its delivery in HeLa cells investigated. Breakable nanodonuts: Hybrid organosilica toroidal particles (see figure) containing a short peptide sequence as the organic component are reported. Once internalised in cancer cells, peptidase enzymes attack the nanocarriers effectively triggering their structural breakdown. These biodegradable nanovectors are also characterised by high cellular uptake and exocytosis, and therefore they have been challenged as biodegradable drug carriers.
Bibliography:SACS Project - No. 310651
Foundation ARC through the project "Thera-HCC" - No. IHU201301187
ArticleID:CHEM201504605
European Union - No. 247365
ark:/67375/WNG-QX76GW72-N
istex:44B2A4B596F9742F917021A809A10193CFC69C5B
AXA Research funds
Marie Skłodowska-Curie Actions Intra-European Fellowship - No. 627788
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0947-6539
1521-3765
DOI:10.1002/chem.201504605